Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yoshio Ogino
Observed names:
Ogino Yoshio,
YOSHIO OGINO,
Yoshio OGINO
Observed institutions:
National Institutes of Health,
Tokai University,
Kyushu University,
Keio University,
Kyoto Prefectural University of Medicine,
Merck Biopharma Co., Ltd. (Japan),
Eunice Kennedy Shriver National Institute of Child Health and Human Development,
Teikyo University
show all 8
OpenAlex ID:
A5111780658
In vivo effects by estrone sulfate on the central nervous system-senile dementia (alzheimer's type)
1989
·
Honjo Hideo
, Ogino Yoshio
, et al.
·
Journal of Steroid Biochemistry
·
227
Thrombin is a regulator of astrocytic endothelin-1
1993
·
Hannelore Ehrenreich
, Tommaso Costa
, et al.
·
Brain Research
·
94
Estrone sulfate and sulfatase activity in human breast cancer and endometrial cancer
1989
·
Kazuo Naitoh
, Hideo Honjo
, et al.
·
Journal of Steroid Biochemistry
·
68
Modulation of neuropeptide Y receptors for the treatment of obesity
2009
·
Nagaaki Sato
, Yoshio Ogino
, et al.
·
Expert Opinion on Therapeutic Patents
·
59
Discovery of novel 2-(pyridine-2-yl)-1H-benzimidazole derivatives as potent glucokinase activators
2009
·
Makoto Ishikawa
, Katsumasa Nonoshita
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
53
J-104129, a novel muscarinic M3 receptor antagonist with high selectivity for M3 over M2 receptors
1999
·
Morihiro Mitsuya
, Toshiaki Mase
, et al.
·
Bioorganic & Medicinal Chemistry
·
48
Design, syntheses, and structure–activity relationships of novel NPY Y5 receptor antagonists: 2-{3-Oxospiro[isobenzofuran-1(3H),4′-piperidin]-1′-yl}benzimidazole derivatives
2008
·
Yoshio Ogino
, Norikazu Ohtake
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
46
A Potent, Long-Acting, Orally Active (2R)-2-[(1R)-3,3-Difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: A Novel Muscarinic M3 Receptor Antagonist with High Selectivity for M3 over M2 Receptors
2000
·
Morihiro Mitsuya
, Kensuke Kobayashi
, et al.
·
Journal of Medicinal Chemistry
·
46
Pituitary Somatotroph Adenoma Producing Growth Hormone (GH)-Releasing Hormone (GHRH) with an Elevated Plasma GHRH Concentration: A Model Case for Autocrine and Paracrine Regulation of GH Secretion by GHRH1
1999
·
Akira Matsuno
, Hideki Katakami
, et al.
·
The Journal of Clinical Endocrinology & Metabolism
·
28
Direct evidence for two distinct G proteins coupling with thrombin receptors in human neuroblastoma SH-EP cells
1996
·
Yoshio Ogino
, Koshi Tanaka
, et al.
·
European Journal of Pharmacology
·
25
Syntheses and structure–activity relationships of novel, potent, and selective trans-2-[3-oxospiro[isobenzofuran-1(3H),1′-cyclohexan]-4′-yl]benzimidazole NPY Y5 receptor antagonists
2008
·
Yoshio Ogino
, Norikazu Ohtake
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
23
Effects of endothelin-1 on Ca2+ signaling and secretion in parathyroid cells
1995
·
Yoshio Fujii
, Melanija Tomić
, et al.
·
Journal of Bone and Mineral Research
·
22
Diastereoselective Synthesis of the Acid Part of a New Muscarinic M3 Receptor Antagonist
2000
·
Morihiro Mitsuya
, Yoshio Ogino
, et al.
·
Tetrahedron
·
21
Stereoselective synthesis of a new muscarinic M3 receptor antagonist, J-104129
1999
·
Morihiro Mitsuya
, Kumiko Kawakami
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
21
The Epithelial Phenotype of Human Neuroblastoma Cells Expresses Bradykinin, Endothelin, and Angiotensin II Receptors That Stimulate Phosphoinositide Hydrolysis
1992
·
Yoshio Ogino
, Tommaso Costa
·
Journal of Neurochemistry
·
19
A case of a gallbladder cancer with marked hypercalcemia and leukocytosis.
1989
·
Yumiko WATANABE
, Yoshio OGINO
, et al.
·
Japanese Journal of Medicine
·
19
PDF
Discovery of a muscarinic M3 receptor antagonist with high selectivity for M3 over M2 receptors among 2-[(1S,3S)-3-sulfonylaminocyclopentyl]phenylacetamide derivatives
2000
·
Morihiro Mitsuya
, Yoshio Ogino
, et al.
·
Bioorganic & Medicinal Chemistry
·
18
Muscarinic M3 receptor antagonists with (2R)-2-[(1R)-3,3-Difluorocyclopentyl]-2-hydroxyphenylacetamide Structures. Part 2
2003
·
Yoshio Ogino
, Norikazu Ohtake
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
14
Selective M3 Muscarinic Receptor Antagonist Inhibits Small-Cell Lung Carcinoma Growth in a Mouse Orthotopic Xenograft Model
2011
·
Nozomi Ami
, Kazumi Koga
, et al.
·
Journal of Pharmacological Sciences
·
13
PDF
Discovery of 2-Aminothiazole-4-carboxamides, a Novel Class of Muscarinic M3 Selective Antagonists, through Solution-Phase Parallel Synthesis
2005
·
Yufu Sagara
, Morihiro Mitsuya
, et al.
·
Chemical and Pharmaceutical Bulletin
·
12
PDF
Serum estradiol 17-sulphate and lipid peroxides in late pregnancy
1992
·
Hideo Honjo
, Kazunori Tanaka
, et al.
·
European Journal of Endocrinology
·
12
The Role of Arginine in Thrombin Receptor Tethered-Ligand Peptide in Intramolecular Receptor Binding and Self-Activation
1998
·
Takeru Nose
, Yusuke Satoh
, et al.
·
Bulletin of the Chemical Society of Japan
·
9
Structural Essentials of Ser-1 in Tethered Peptide Ligand of Human Thrombin Receptor for Phosphoinositide Hydrolysis
1994
·
Kazuyasu Sakaguchi
, Hiroaki Kodama
, et al.
·
Bulletin of the Chemical Society of Japan
·
9
A facile enantioselective synthesis of (1R, 2R, 3S)-1-amino-2,3-bishydroxymethylcyclobutane derivatives, a key synthetic intermediate of carbocyclic oxetanocins
1992
·
Takao Izawa
, Yoshio Ogino
, et al.
·
Tetrahedron
·
9
Detection of a Silent Pituitary Somatotroph Adenoma in a Patient with Amenorrhea and/or Galactorrhea
2000
·
AKIRA MATSUNO
, YOSHIO OGINO
, et al.
·
Endocrine Journal
·
8
PDF
Show more works
View as search
Works count:
48
Citation count:
974
H-index:
17
I10-index:
21
Year
Topic
Type